FDA inspection
Novartis Pharma AG: FDA inspection ending Aug 30, 2022
FDA inspection 1180833 · Voluntary Action Indicated (VAI) · Basel Town
Key facts
| Inspection ID | 1180833 |
|---|---|
| Firm | Novartis Pharma AG |
| FEI number | 3002807772 |
| Address | Lichtstrasse 35 |
| City | Basel Town |
| Country | Switzerland |
| Fiscal year | 2022 |
| Inspection end date | Aug 30, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data